SCHEMBL31039223

SCHEMBL31039223

FC(F)(F)c1cc(-c2cn[nH]c2)cc(Cl)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPBWR1 P48145 2/20 0.44
▸ ADORA2A P29274 2/20 0.40
▸ ADORA1 P30542 1/20 0.40
▸ AKT2 P31751 6/20 0.38
▸ AKT1 P31749 4/20 0.38
▸ HSD17B10 Q99714 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ FDPS P14324 1/20 0.35
▸ EPHB4 P54760 1/20 0.35
▸ IDO1 P14902 1/20 0.35
▸ PRKACA P17612 2/20 0.35
▸ AKT3 Q9Y243 2/20 0.35
▸ PRKCD Q05655 2/20 0.35
▸ ROCK2 O75116 1/20 0.35
▸ RPS6KA5 O75582 1/20 0.35
▸ RPS6KA4 O75676 1/20 0.35
▸ LATS1 O95835 1/20 0.35
▸ PRKACB P22694 1/20 0.35
▸ RPS6KB1 P23443 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1365945 0.82 AKT1 (0.48) NPBWR1AKT2AKT1PRKACAAKT3
SCHEMBL30060444 0.74 KDM4E (0.41) NPBWR1AKT2AKT1HSD17B10KDM4E
SCHEMBL3560817 0.73 KDM4E (0.54) ADORA2AADORA1HSD17B10KDM4EALDH1A1
SCHEMBL17675343 0.72 IDO1 (0.60) NPBWR1AKT2AKT1IDO1AURKA
SCHEMBL3561230 0.71 ADORA2A (0.49) ADORA2AADORA1HSD17B10KDM4EALDH1A1
SCHEMBL29533228 0.70 AKT2 (0.61) AKT2AKT1ROCK2RPS6KA3ABL1
SCHEMBL15849790 0.70 AKT2 (0.61) AKT2AKT1ROCK2RPS6KA3ABL1
SCHEMBL16700734 0.69 AKT1 (0.47) NPBWR1AKT2AKT1
SCHEMBL25798414 0.69 NPBWR1 (0.44) NPBWR1AKT2AKT1FDPSEPHB4
SCHEMBL7262587 0.68 NPBWR1 (0.40) NPBWR1ADORA2AADORA1AKT2AKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4655296-A1 CBL-B INHIBITORS Aurigene Oncology Limited (IN) 2025-12-03 — — EP disclosed
WO-2024156938-A1 CBL-B INHIBITORS ORION CORPORATION (FI) 2024-08-02 — — WO disclosed
Send feedback